4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0000950170-24-065900
Options or other derivatives
- Chief Commercial Officer acquired 525,000 shares (grant or award)
From the SEC's structured data for this filing
Cogent Biosciences, Inc. Filed Acc 0000950170-24-065900
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…